Literature DB >> 26161295

In Vitro Anticancer Activity of the Crude Extract and two Dicinnamate Isolates from the Jamaican Ball Moss (Tillandsia Recurvata L.).

Henry Ic Lowe1, Ngeh J Toyang2, Charah Watson3, Simone Badal4, Perceval Bahado-Singh5, Joseph Bryant6.   

Abstract

A crude chloroform extract from the Jamaican Ball Moss (Tillandsia recurvata L.) was tested for activity against three human cancer cell lines including; A375 (human melanoma), MCF-7 (human breast) and PC-3 (human prostate cancer) using the WST-1 assay. IC50s obtained against these cell lines; A375, MCF-7 and PC-3 in the presence of the crude extract are; 0.9μg/ml, 40.51μg/ml and 5.97μg/ml respectively indicating the promising anti-cancer activity of the ball moss extract. Further, preliminary phytochemical study was conducted in an attempt to identify and isolate the phytochemicals that could possibly be responsible for the observed bioactivity of the ball moss chloroform extract. As a result, two dicinnamates were isolated; 1,3-di-O-Cinnamoyl-glycerol (1) and (E)-3-(cinnamoyloxy)-2-hydroxypropyl 3-(3,4-dimethoxyphenyl)acrylate (2) and we report for the first time isolation of compound 2. Even though the bioactivity of these two islaotes were fairly weak against the cell lines, the results presented here will prove useful for further research aimed at identifying molecules that maybe effective against melanoma, breast and prostate cancers associated with fewer side-effects.

Entities:  

Keywords:  Jamaican Ball Moss; Tillandsia recurvata; breast cancer; dicinnamates; melanoma; prostate cancer

Year:  2013        PMID: 26161295      PMCID: PMC4493924     

Source DB:  PubMed          Journal:  Am Int J Contemp Res


  3 in total

1.  Chemical constituents from Tillandsia recurvata.

Authors:  Marcos Aurélio de Queiroga; Lucimara Mariano de Andrade; Karina Chagas Florêncio; Maria de Fátima Agra; Marcelo Sobral da Silva; José Maria Barbosa-Filho; Emidio Vasconcelos Leitão da-Cunha
Journal:  Fitoterapia       Date:  2004-06       Impact factor: 2.882

Review 2.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

3.  WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line.

Authors:  Puriya Ngamwongsatit; Padmapriya P Banada; Watanalai Panbangred; Arun K Bhunia
Journal:  J Microbiol Methods       Date:  2008-03-13       Impact factor: 2.363

  3 in total
  5 in total

1.  Antileukemic activity of Tillandsia recurvata and some of its cycloartanes.

Authors:  Henry I C Lowe; Ngeh J Toyang; Charah T Watson; Kenneth N N Ayeah; Joseph Bryant
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

2.  HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L.

Authors:  Henry I C Lowe; Ngeh J Toyang; Charah T Watson; Kenneth N Ayeah; Joseph Bryant
Journal:  Cancer Cell Int       Date:  2017-03-07       Impact factor: 5.722

Review 3.  A Review of Cytotoxic Plants of the Indian Subcontinent and a Broad-Spectrum Analysis of Their Bioactive Compounds.

Authors:  Kishor Mazumder; Biswajit Biswas; Iqbal Mahmud Raja; Koichi Fukase
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

4.  Cytotoxic Fractions from Hechtia glomerata Extracts and p-Coumaric Acid as MAPK Inhibitors.

Authors:  Tommaso Stefani; Antonio Romo-Mancillas; Juan J J Carrizales-Castillo; Eder Arredondo-Espinoza; Karla Ramírez-Estrada; Victor M Alcantar-Rosales; Leticia González-Maya; Jessica Nayelli Sánchez-Carranza; Isaías Balderas-Renterías; María Del Rayo Camacho-Corona
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

5.  Isolation and Identification of Flavones Responsible for the Antibacterial Activities of Tillandsia bergeri Extracts.

Authors:  Mame-Marietou Lo; Zohra Benfodda; Catherine Dunyach-Rémy; David Bénimélis; Romain Roulard; Jean-Xavier Fontaine; David Mathiron; Anthony Quéro; Roland Molinié; Patrick Meffre
Journal:  ACS Omega       Date:  2022-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.